Compare Stocks: ZTS, KNSL, MEDP, and MSCI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KNSL Kinsale Capital Group	$376.96 +1.2%	$358.67	$287.20 ▼ $485.00	$8.49B	0.89	198,613 shs	190,938 shs
MEDP Medpace	$593.02 +1.7%	$571.91	$373.00 ▼ $677.90	$16.28B	1.15	202,336 shs	204,194 shs
MSCI MSCI	$562.03 -0.2%	$578.61	$501.08 ▼ $644.77	$40.94B	1.22	578,493 shs	397,222 shs
ZTS Zoetis	$76.22 -1.3%	$75.56	$71.00 ▼ $155.15	$31.92B	0.73	6.47 million shs	4.47 million shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KNSL Kinsale Capital Group	-0.57%	-4.23%	+4.03%	+28.02%	-18.83%
MEDP Medpace	-1.81%	-5.02%	+1.06%	+29.37%	+22.65%
MSCI MSCI	-1.68%	-0.30%	-1.99%	-8.43%	-0.91%
ZTS Zoetis	+0.27%	-0.12%	-0.22%	-0.40%	-50.66%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KNSL Kinsale Capital Group	$376.96 +1.2%	$358.67	$287.20 ▼ $485.00	$8.49B	0.89	198,613 shs	190,938 shs
MEDP Medpace	$593.02 +1.7%	$571.91	$373.00 ▼ $677.90	$16.28B	1.15	202,336 shs	204,194 shs
MSCI MSCI	$562.03 -0.2%	$578.61	$501.08 ▼ $644.77	$40.94B	1.22	578,493 shs	397,222 shs
ZTS Zoetis	$76.22 -1.3%	$75.56	$71.00 ▼ $155.15	$31.92B	0.73	6.47 million shs	4.47 million shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KNSL Kinsale Capital Group	-0.57%	-4.23%	+4.03%	+28.02%	-18.83%
MEDP Medpace	-1.81%	-5.02%	+1.06%	+29.37%	+22.65%
MSCI MSCI	-1.68%	-0.30%	-1.99%	-8.43%	-0.91%
ZTS Zoetis	+0.27%	-0.12%	-0.22%	-0.40%	-50.66%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
KNSL Kinsale Capital Group	1.90	Reduce	$368.78	-2.17% Downside
MEDP Medpace	2.23	Hold	$584.18	-1.49% Downside
MSCI MSCI	3.08	Buy	$709.50	26.24% Upside
ZTS Zoetis	2.32	Hold	$107.43	40.94% Upside

Current Analyst Ratings Breakdown

Latest ZTS, KNSL, MEDP, and MSCI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2026	ZTS Zoetis	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$104.00 ➝ $94.00
8/25/2026	ZTS Zoetis	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$94.00
8/20/2026	ZTS Zoetis	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$85.00 ➝ $80.00
8/19/2026	KNSL Kinsale Capital Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
8/19/2026	KNSL Kinsale Capital Group	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$345.00 ➝ $390.00
8/12/2026	MEDP Medpace	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
8/11/2026	ZTS Zoetis	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$112.00 ➝ $96.00
8/11/2026	ZTS Zoetis	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$146.00 ➝ $110.00
8/10/2026	ZTS Zoetis	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/10/2026	ZTS Zoetis	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$90.00 ➝ $80.00
8/7/2026	ZTS Zoetis	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$85.00

(Data available from 9/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
KNSL Kinsale Capital Group	$1.87B	4.58	$20.09 per share	18.76	$89.34 per share	4.22
MEDP Medpace	$2.53B	6.54	$17.30 per share	34.28	$15.54 per share	38.16
MSCI MSCI	$3.13B	13.04	$21.04 per share	26.71	($36.99) per share	-15.19
ZTS Zoetis	$9.47B	3.33	$7.47 per share	10.21	$7.62 per share	10.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
KNSL Kinsale Capital Group	$503.61M	$24.68	15.27	17.54	1.18	28.49%	25.54%	8.15%	10/22/2026 (Estimated)
MEDP Medpace	$451.12M	$17.06	34.76	30.93	2.60	17.67%	110.15%	24.84%	10/28/2026 (Estimated)
MSCI MSCI	$1.20B	$18.28	30.75	25.15	2.15	40.74%	-55.19%	24.90%	10/20/2026 (Estimated)
ZTS Zoetis	$2.67B	$6.07	12.56	12.04	1.80	27.49%	74.89%	18.59%	11/3/2026 (Estimated)

Latest ZTS, KNSL, MEDP, and MSCI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	ZTS Zoetis	$1.85	$1.87	+$0.02	$1.65	$2.50 billion	$2.47 billion
7/23/2026	Q2 2026	KNSL Kinsale Capital Group	$5.11	$5.54	+$0.43	$7.72	$445.14 million	$548.52 million
7/22/2026	Q2 2026	MEDP Medpace	$3.98	$4.25	+$0.27	$4.25	$689.51 million	$707.33 million
7/21/2026	Q2 2026	MSCI MSCI	$4.99	$4.94	-$0.05	$4.69	$870.71 million	$867.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
KNSL Kinsale Capital Group	$1.00	0.27%	+13.56%	4.05%	2 Years
MEDP Medpace	N/A	N/A	N/A	N/A	N/A
MSCI MSCI	$8.20	1.46%	+19.78%	44.86%	11 Years
ZTS Zoetis	$2.12	2.78%	+20.11%	34.93%	14 Years

Latest ZTS, KNSL, MEDP, and MSCI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/12/2026	KNSL Kinsale Capital Group	quarterly	$0.25	0.26%	8/28/2026	8/28/2026	9/14/2026
7/20/2026	MSCI MSCI	quarterly	$2.05	1.44%	8/14/2026	8/14/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
KNSL Kinsale Capital Group	0.11	0.09	0.09
MEDP Medpace	N/A	0.73	0.73
MSCI MSCI	N/A	0.89	0.89
ZTS Zoetis	2.87	3.08	1.84

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
KNSL Kinsale Capital Group	85.36%
MEDP Medpace	77.98%
MSCI MSCI	89.97%
ZTS Zoetis	92.80%

Insider Ownership

Company	Insider Ownership
KNSL Kinsale Capital Group	5.60%
MEDP Medpace	20.50%
MSCI MSCI	3.76%
ZTS Zoetis	0.22%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
KNSL Kinsale Capital Group	470	22.78 million	21.50 million	Optionable
MEDP Medpace	6,200	27.91 million	22.19 million	Optionable
MSCI MSCI	6,268	72.70 million	69.97 million	Optionable
ZTS Zoetis	14,500	413.22 million	412.32 million	Optionable

ZTS, KNSL, MEDP, and MSCI Headlines

Recent News About These Companies

Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

September 2 at 7:30 AM | businesswire.com

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Decreases Holdings in Zoetis Inc. $ZTS

September 1 at 5:28 AM | marketbeat.com

Public Employees Retirement System of Ohio Takes Position in Zoetis Inc. $ZTS

September 1 at 5:03 AM | marketbeat.com

Zoetis Inc. $ZTS Shares Purchased by Clifford Swan Investment Counsel LLC

September 1 at 4:16 AM | marketbeat.com

Kerrisdale Advisers LLC Acquires Shares of 42,000 Zoetis Inc. $ZTS

August 31 at 6:15 AM | marketbeat.com

Quantitative Investment Management LLC Purchases Shares of 45,119 Zoetis Inc. $ZTS

August 31 at 6:08 AM | marketbeat.com

Moore Capital Management LP Acquires Shares of 202,749 Zoetis Inc. $ZTS

August 31 at 6:00 AM | marketbeat.com

Two Sigma Securities LLC Invests $3.05 Million in Zoetis Inc. $ZTS

August 31 at 5:52 AM | marketbeat.com

Headlands Technologies LLC Acquires Shares of 55,106 Zoetis Inc. $ZTS

August 31 at 4:16 AM | marketbeat.com

Benjamin Edwards Inc. Cuts Stake in Zoetis Inc. $ZTS

August 31 at 4:16 AM | marketbeat.com

Flputnam Investment Management Co. Has $2.17 Million Stock Holdings in Zoetis Inc. $ZTS

August 31 at 4:08 AM | marketbeat.com

Phibro Animal Health: Zoetis Integrated And Better Cash Flow Ahead

August 30 at 8:30 AM | seekingalpha.com

Wellington Management Group LLP Sells 726,201 Shares of Zoetis Inc. $ZTS

August 30 at 5:36 AM | marketbeat.com

Davidson Investment Advisors Raises Position in Zoetis Inc. $ZTS

August 30 at 4:32 AM | marketbeat.com

Van ECK Associates Corp Purchases 303,395 Shares of Zoetis Inc. $ZTS

August 29, 2026 | marketbeat.com

Blackhill Capital Inc. Cuts Stock Position in Zoetis Inc. $ZTS

August 29, 2026 | marketbeat.com

Dearborn Partners LLC Invests $1.72 Million in Zoetis Inc. $ZTS

August 28, 2026 | marketbeat.com

Zoetis Inc Class A ZTS

August 27, 2026 | morningstar.comM

Ancora Advisors LLC Makes New $2.64 Million Investment in Zoetis Inc. $ZTS

August 27, 2026 | marketbeat.com

TD Cowen Sticks to Their Buy Rating for Zoetis (ZTS)

August 26, 2026 | theglobeandmail.com

Hsbc Holdings PLC Reduces Stock Holdings in Zoetis Inc. $ZTS

August 26, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZTS, KNSL, MEDP, and MSCI Company Descriptions

Kinsale Capital Group NYSE:KNSL

$376.96 +4.45 (+1.19%)

Closing price 03:59 PM Eastern

Extended Trading

$377.10 +0.15 (+0.04%)

As of 07:30 PM Eastern

Kinsale Capital Group, Inc., a specialty insurance company, engages in the provision of property and casualty insurance products in the United States. The company's commercial lines offerings include commercial property, small business casualty and property, excess and general casualty, construction, allied health, life sciences, entertainment, energy, environmental, excess professional, health care, public entity, commercial auto, inland marine, aviation, ocean marine, product recall, and railroad, as well as product, professional, and management liability insurance. It markets and sells its insurance products in all 50 states, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands primarily through a network of independent insurance brokers. The company was founded in 2009 and is headquartered in Richmond, Virginia.

Medpace NASDAQ:MEDP

$593.02 +9.81 (+1.68%)

Closing price 04:00 PM Eastern

Extended Trading

$592.98 -0.04 (-0.01%)

As of 07:30 PM Eastern

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

MSCI NYSE:MSCI

$562.03 -1.06 (-0.19%)

Closing price 03:59 PM Eastern

Extended Trading

$563.22 +1.19 (+0.21%)

As of 07:30 PM Eastern

MSCI Inc., together with its subsidiaries, provides critical decision support tools and solutions for the investment community to manage investment processes worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial product, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct. The Analytics segment offers risk management, performance attribution and portfolio management content, application, an integrated view of risk and return service, and an analysis of market, credit, liquidity, counterparty, and climate risk across asset classes; managed services, including consolidation of client portfolio data, review and reconciliation of input data and results, and customized reporting; and HedgePlatform to measure, evaluate, and monitor the risk of hedge fund investments. The ESG and Climate segment provides products and services that help institutional investors understand how ESG impacts the long-term risk and return of their portfolio and individual security-level investments; and data, ratings, research, and tools to help investors navigate increasing regulation. The All Other Private Assets segment includes real estate and infrastructure data, benchmarks, return-analytics, climate assessments and market insights; business intelligence to real estate owners, managers, developers, and brokers; and offers investment decision support tools for private capital. The Private Capital Solutions segment offers tools to help private asset investors across mission-critical workflows, such as sourcing terms and conditions, evaluating operating performance, managing risk and other activities supporting private capital investing. MSCI Inc. was incorporated in 1998 and is headquartered in New York, New York.

Zoetis NYSE:ZTS

$76.22 -1.03 (-1.33%)

Closing price 03:59 PM Eastern

Extended Trading

$76.65 +0.43 (+0.57%)

As of 07:55 PM Eastern

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZTS, KNSL, MEDP, and MSCI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZTS, KNSL, MEDP, and MSCI Earnings

Compare Dividends

Latest ZTS, KNSL, MEDP, and MSCI Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZTS, KNSL, MEDP, and MSCI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZTS, KNSL, MEDP, and MSCI Company Descriptions

Kinsale Capital Group NYSE:KNSL

Medpace NASDAQ:MEDP

MSCI NYSE:MSCI

Zoetis NYSE:ZTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZTS, KNSL, MEDP, and MSCI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZTS, KNSL, MEDP, and MSCI Earnings

Compare Dividends

Latest ZTS, KNSL, MEDP, and MSCI Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZTS, KNSL, MEDP, and MSCI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZTS, KNSL, MEDP, and MSCI Company Descriptions

Kinsale Capital Group NYSE:KNSL

Medpace NASDAQ:MEDP

MSCI NYSE:MSCI

Zoetis NYSE:ZTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools